References
- Waris G, Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog 2006;5:14
- Scandalios JG. The rise of ROS. Trends Biochem Sci 2002;27:483–6
- Klein JA, Ackerman SL. Oxidative stress, cell cycle, and neurodegeneration. J Clin Invest 2003;111:785–93
- Ahsan H, Ali A, Ali R. Oxygen free radicals and systemic autoimmunity. Clin Exp Immunol 2003;131:398–404
- Knight JA. Diseases related to oxygen-derived free radicals. Ann Clin Lab Sci 1995;25:111–21
- Waris G, Alam K. Attenuated antigenicity of ribonucleoproteins modified by reactive oxygen species. Biochem Mol Biol Int 1998;45:33–45
- Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1–Nrf2–ARE pathway. Annu Rev Pharmacol Toxicol 2007;47:89–116
- Kobayashi M, Li L, Iwamoto N, et al. The antioxidant defense system Keap1–Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds. Mol Cell Biol 2009;29:493–502
- McMahon M, Lamont DJ, Beattie KA, Hayes JD. Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals. Proc Natl Acad Sci USA 2010;107:18838–43
- Dinkova-Kostova AT, Holtzclaw WD, Cole RN, et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA 2002;99:11908–13
- Li J, Ichikawa T, Janicki JS, Cui T. Targeting the Nrf2 pathway against cardiovascular disease. Expert Opin Ther Targets 2009;13:785–94
- Zhao J, Redell JB, Moore AN, Dash PK. A novel strategy to activate cytoprotective genes in the injured brain. Biochem Biophys Res Commun 2011;407:501–6
- Steel R, Cowan J, Payerne E, et al. Anti-inflammatory effect of a cell-penetrating peptide targeting the Nrf2/Keap1 interaction. ACS Med Chem Lett 2012;3:407–10
- Williamson TP, Amirahmadi S, Joshi G, et al. Discovery of potent, novel Nrf2 inducers via quantum modeling, virtual screening, and in vitro experimental validation. Chem Biol Drug Des 2012;80:810–20
- Hu L, Magesh S, Chen L, et al. Discovery of a small-molecule inhibitor and cellular probe of Keap1–Nrf2 protein–protein interaction. Bioorg Med Chem Lett 2013;23:3039–43
- Zhuang C, Miao Z, Sheng C, Zhang W. Updated research and applications of small molecule inhibitors of Keap1–Nrf2 protein–protein interaction: a review. Curr Med Chem 2014;21:1861–70
- Nesterova NA, Kovalenko SI, Belenichev IF, et al. Formation of combinational library of quinazoline-4-yl-hydrazones with antioxidant activity. Ukraine Med Khim 2004;6:14–21
- Nesterova NA, Kovalenko SI, Karpenkos OV, Belenichev IF. Synthesis and antioxidant activity of 4-arylidenehydrazinoquinazolines. Ukr Farmatsevtichnii Zhurnal (Kiev) 2004;22:5–10
- Al-Omar MA, Al-Rashood ST, El-Subbagh HI, Abdel Hamide SG. Interaction of 2-thio-4-oxo-quinazoline derivatives with guinea pig liver molybdenum hydroxylases, xanthine oxidase and aldehyde oxidase. J Biol Sci 2005;5:370–8
- Ghorab MM, Higgins M, Alsaid MS, et al. Synthesis, molecular modeling and NAD(P)H:quinone oxidoreductase 1 inducer activity of novel cyanoenone and enone benzenesulfonamides. J Enzyme Inhib Med Chem 2014;29:840–5
- Ghorab MM, Higgins M, Dinkova-Kostova AT, et al. Novel thioureido derivatives carrying thione and sulfonamide moieties induce the cytoprotective enzyme NAD(P)H:quinone oxidoreductase 1. Asian J Chem 2014;26:8501–4
- Prochaska HJ, Santamaria AB. Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: a screening assay for anticarcinogenic enzyme inducers. Anal Biochem 1988;169:328–36
- Marcotte D, Zeng W, Hus JC, et al. Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a noncovalent mechanism. Bioorg Med Chem 2013;21:4011–19
- Magesh S, Chen Y, Hu L. Small molecule modulators of Keap1–Nrf2–ARE pathway as potential preventive and therapeutic agents. Med Res Rev 2012;32:687–726
- Bertrand HC, Schaap M, Baird L, et al. Design, synthesis, and evaluation of triazole derivatives that induce Nrf2 dependent gene products and inhibit the Keap1–Nrf2 protein–protein interaction. J Med Chem 2015;58:7186–94